|
English
|
正體中文
|
简体中文
|
總筆數 :2853777
|
|
造訪人次 :
45277452
線上人數 :
750
教育部委託研究計畫 計畫執行:國立臺灣大學圖書館
|
|
|
顯示項目 505946-505955 / 2346288 (共234629頁)
<< < 50590 50591 50592 50593 50594 50595 50596 50597 50598 50599 > >>
每頁顯示[10|25|50]項目
| 國家衛生研究院 |
2009-09-15 |
Induction of Bim expression contributes to the antitumor synergy between sorafenib and mitogen-activated protein kinase/extracellular signal-regulated kinase kinase inhibitor CI-1040 in hepatocellular carcinoma
|
Ou, DL;Shen, YC;Liang, JD;Liou, JY;Yu, SL;Fan, HH;Wang, DS;Lu, YS;Hsu, C;Cheng, AL |
| 臺大學術典藏 |
2022-08-19T00:21:05Z |
Induction of Bim expression contributes to the antitumor synergy between sorafenib and mitogen-activated protein kinase/extracellular signal-regulated kinase kinase inhibitor CI-1040 in hepatocellular carcinoma
|
Cheng A.-L.; CHIUN HSU; Wang D.-S.; Lu Y.-S.; Fan H.-H.; Ou D.-L.; Shen Y.-C.; Liang J.-D.; Liou J.-Y.; Yu S.-L. |
| 國立臺灣大學 |
2009 |
INDUCTION OF BIM EXPRESSION CONTRIBUTES TO THE ANTITUMOR SYNERGY BETWEEN SORAFENIB AND MITOGEN-ACTIVATED PROTEIN KINASE/EXTRACELLULAR SIGNAL-REGULATED KINASE KINASE INHIBITOR CI-1040 IN HEPATOCELLULAR CARCINOMA
|
歐大諒; 沈盈君; 梁嘉德; 劉俊陽; 俞松良; 盧彥伸; 許駿 |
| 臺大學術典藏 |
2020-04-10T12:51:21Z |
Induction of Bim expression contributes to the antitumor synergy between sorafenib and mitogen-activated protein kinase/extracellular signal-regulated kinase kinase inhibitor CI-1040 in hepatocellular carcinoma
|
Ou D.-L.; Shen Y.-C.; Liang J.-D.; Liou J.-Y.; Yu S.-L.; Fan H.-H.; Wang D.-S.; Lu Y.-S.; Chiun Hsu; Cheng A.-L. |
| 臺大學術典藏 |
2020-05-25T06:52:04Z |
Induction of Bim expression contributes to the antitumor synergy between sorafenib and mitogen-activated protein kinase/extracellular signal-regulated kinase kinase inhibitor CI-1040 in hepatocellular carcinoma
|
Cheng A.-L.;Hsu C;Yen-Shen Lu;Wang D.-S;Fan H.-H;Yu S.-L;Liou J.-Y;Liang J.-D;Shen Y.-C;Ou D.-L; Ou D.-L; Shen Y.-C; Liang J.-D; Liou J.-Y; Yu S.-L; Fan H.-H; Wang D.-S; YEN-SHEN LU; Hsu C; Cheng A.-L. |
| 臺大學術典藏 |
2021-03-09T05:18:38Z |
Induction of Bim expression contributes to the antitumor synergy between sorafenib and mitogen-activated protein kinase/extracellular signal-regulated kinase kinase inhibitor CI-1040 in hepatocellular carcinoma
|
Ou D.-L.; Ying-Chun Shen; Liang J.-D.; Liou J.-Y.; Yu S.-L.; Fan H.-H.; Wang D.-S.; Lu Y.-S.; Hsu C.; Cheng A.-L. |
| 國立臺灣大學 |
2015 |
Induction of c-Cbl contributes to anti-cancer effects of HDAC inhibitor in lung cancer
|
Wei, Tzu-Tang; Lin, Yu-Chin; Lin, Pei-Hua; Shih, Jin-Yuan; Chou, Chia-Wei; Huang, Wei-Jan; Yang, Yu-Chih; Hsiao, Pei-Wen; Chen, Ching-Chow; 施金元; 陳青周 |
| 臺大學術典藏 |
2015 |
Induction of c-Cbl contributes to anti-cancer effects of HDAC inhibitor in lung cancer
|
Wei, T.-T. and Lin, Y.-C. and Lin, P.-H. and Shih, J.-Y. and Chou, C.-W. and Huang, W.-J. and Yang, Y.-C. and Hsiao, P.-W. and Chen, C.-C.; JIN-YUAN SHIH |
| 臺大學術典藏 |
2020-08-13T06:33:44Z |
Induction of c-Cbl contributes to anti-cancer effects of HDAC inhibitor in lung cancer
|
Wei T.-T.; Lin Y.-C.; Lin P.-H.; JIN-YUAN SHIH; Chou C.-W.; Huang W.-J.; Yang Y.-C.; Hsiao P.-W.; Chen C.-C. |
| 臺大學術典藏 |
2015 |
Induction of c-Cbl contributes to anti-cancer effects of HDAC inhibitor in lung cancer
|
TZU-TANG WEI; Lin Y.-C.; Lin P.-H.; Shih J.-Y.; Chou C.-W.; Huang W.-J.; Yang Y.-C.; Hsiao P.-W.; Chen C.-C. |
顯示項目 505946-505955 / 2346288 (共234629頁)
<< < 50590 50591 50592 50593 50594 50595 50596 50597 50598 50599 > >>
每頁顯示[10|25|50]項目
|
